other material
confidence high
sentiment neutral
materiality 0.50
Mangoceuticals sells 250 Series B Preferred shares for $250,000 in fourth closing under SPA
MANGOCEUTICALS, INC.
- Sold 250 Series B Preferred shares to institutional accredited investor for $250,000; effective price at 10% discount to $1,100 stated value.
- Total 750 of 1,000 possible Series B shares sold to date; 250 remain available for future sale.
- Full conversion at $0.15 floor price yields 1,833,333 common shares; shareholder approval obtained for >19.99% issuance.
- Issuance exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.